Alternariosis after liver transplantation

N Benito1, A Moreno, J Puig

  • 1Institut Clínic d' Infeccions i Inmunologia, IDIBAPS, Hospital Clínic, Universitat de Barcelona, Spain. nbenito@clinic.ub.es

Transplantation
|December 12, 2001
PubMed

Insights

Alternaria fungal infections are a growing concern in organ transplant recipients. This review highlights a liver transplant case and discusses optimal antifungal treatments for alternariosis in these vulnerable patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • Alternaria, a saprophytic fungus, is an emerging human pathogen.
  • Immunocompromised individuals, especially solid-organ transplant recipients, are at higher risk.
  • Optimal antifungal therapy for alternariosis remains undefined.

Observation:

  • A case of alternariosis following orthotopic liver transplantation is presented.
  • Literature on Alternaria infections in organ transplant recipients is reviewed.
  • Focus is placed on treatment strategies for these infections.

Findings:

  • Combined surgical and medical management show promise for alternariosis.
  • Limited case reports exist for liver transplant recipients with this infection.
  • Further research is needed to establish definitive treatment protocols.

Implications:

  • This case adds to the limited understanding of Alternaria infections post-liver transplant.
  • The review emphasizes the need for defined antifungal treatment guidelines.
  • Improved management strategies are crucial for improving outcomes in transplant patients.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...